Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$26.24 - $39.63 $125,374 - $189,352
-4,778 Reduced 94.06%
302 $11,000
Q1 2023

May 15, 2023

BUY
$18.67 - $24.56 $94,843 - $124,764
5,080 New
5,080 $123,000
Q2 2022

Aug 12, 2022

SELL
$9.12 - $18.9 $766 - $1,587
-84 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$12.15 - $16.83 $1,020 - $1,413
84 New
84 $1,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.